CHANDRA BHAGAT PHARMA Fact Sheet, CHANDRA BHAGAT PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CHANDRA BHAGAT PHARMA Fact Sheet    (CBPL)


FREE REPLAY: Catch the Details of Potential Crorepati-Making Stocks Right Now...


Here is the latest financial fact sheet of CHANDRA BHAGAT PHARMA. For more details, see the CHANDRA BHAGAT PHARMA quarterly results and CHANDRA BHAGAT PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

CHANDRA BHAGAT PHARMA Price History

Price Rs 88.3
Mkt Cap Rs m 666
Vol '000 2.0
P/E X  
P/CF X 192.2
EPS (TTM) Rs 0.0
1 Day % 5.0
No. of shares m 7.55
1 Week % 14.3
1 Month % -3.5
1 Year % 126.4
52 week H/L Rs 148.5/35.5
As on Jan 20, 2022 03:35:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CHANDRA BHAGAT PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
CHANDRA BHAGAT PHARMA EQUITY SHARE DATA
High RsNANANANA52 
Low RsNANANANA38 
Sales per share (Unadj.) Rs1,901.02,137.82,310.91,586.2124.5 
Earnings per share (Unadj.) Rs8.415.724.610.30.4 
Diluted earnings per shareRs0.50.91.40.90.4 
Cash flow per share (Unadj.) Rs14.219.126.011.00.5 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %NMNMNMNM0 
Book value per share (Unadj.) Rs160.7176.4201.0215.634.0 
Adj. book value per shareRs8.99.811.219.134.0 
Shares outstanding (eoy) m0.420.420.420.677.55 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x00000.4 
Avg P/E ratio x0000108.0 
P/CF ratio (eoy) x000098.0 
Price / Book Value ratio x00001.3 
Dividend payout %00000 
Avg Mkt Cap Rs m0000340 
No. of employees `000NANANANANA 
Total wages/salary Rs m7356504523 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
CHANDRA BHAGAT PHARMA INCOME DATA
Net Sales Rs m7988989711,063940 
Other income Rs m45744 
Total revenues Rs m8029039771,067944 
Gross profit Rs m4344464631 
Depreciation Rs m21110 
Interest Rs m3738374131 
Profit before tax Rs m791594 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m43521 
Profit after tax Rs m471073 
Gross profit margin %5.44.94.74.33.3 
Effective tax rate %51.027.732.522.325.5 
Net profit margin %0.40.71.10.60.3 
CHANDRA BHAGAT PHARMA BALANCE SHEET DATA
Current assets Rs m438553571813729 
Current liabilities Rs m377372286525341 
Net working cap to sales %7.620.229.327.141.3 
Current ratio x1.21.52.01.52.1 
Inventory Days Days0194143 
Debtors Days Days6680679054 
Net fixed assets Rs m76554 
Share capital Rs m444775 
"Free" reserves Rs m637080138181 
Net worth Rs m687484144257 
Long term debt Rs m042117115109 
Total assets Rs m445559580828747 
Interest coverage x1.21.21.41.21.1 
Debt to equity ratio x00.61.40.80.4 
Sales to assets ratio x1.81.61.71.31.3 
Return on assets %9.18.08.15.84.6 
Return on equity %5.28.912.24.81.2 
Return on capital %65.740.625.819.29.7 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m000018 
Fx outflow Rs m00001 
Net fx Rs m000017 
CHANDRA BHAGAT PHARMA CASH FLOW
From Operations Rs m 0 -90 -62 41 -74 
From Investments Rs m 0 3 -4 -4 1 
From Financial Activity Rs m 0 80 65 -37 69 
Net Cashflow Rs m 0 -8 0 -1 -4 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 71.8%
Institution 0.0%
Non-Institution 28.2%
Total 100.0%
Free Float 28.2%
Pledged promoter holdings 0.0%
Shareholding as on Sep 2021
 

Company Information

Regd Off 323 - F Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai - 400019
E-mail compliancecbc@gmail.com Web www.cbcpharma.com
Tel 91-022-24146154 Fax
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 2003 BSE CODE: 542934 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare CHANDRA BHAGAT PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

4 Reasons Why Sensex Plunged 634 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks Views On News (Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CHANDRA BHAGAT PHARMA

  • Track your investment in CHANDRA BHAGAT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CHANDRA BHAGAT PHARMA

CHANDRA BHAGAT PHARMA - GLENMARK PHARMA COMPARISON

COMPARE CHANDRA BHAGAT PHARMA WITH

MARKET STATS